Meet the team

Meet the team that is continually circling the globe to find the emerging frontiers in bioscience, and stewarding our community of pioneering awardees at home. 

Kathy Richmond, Ph.D., M.B.A.

Executive Vice President, Director Frontiers Group and Office of Science and Technology | kathrynr@alleninstitute.org

Dr. Kathryn Richmond is an Executive Vice President at the Allen Institute, leading the Office of Science and Technology and The Paul G. Allen Frontiers Group. In this role, she leads initiatives across the Institute and oversees scientific strategy, government relations, and business development, and is co-Chair of the DE&I Council. With a focus on emerging bioscience and technology areas, she has dramatically grown the Frontiers Group portfolio, overseeing >$250M in award funding to date. Through identification of high-risk, high reward opportunities, the Allen Distinguished Investigator program was expanded, the Allen Discovery Center program was launched, and >$50M in strategic philanthropic partnerships were formed. Dr. Richmond frequently serves as a reviewer for federal agencies and partner organizations for multidisciplinary ‘frontier’ research programs, and as an invited panel member and speaker on topics ranging from science philanthropy to technology development.  She has served on advisory committees and convened the inaugural Bioscience and Philanthropy Summit, engaging thought pioneers, technologists, venture capital leaders and philanthropic funders from around the world.  Previously, she served as a member of the executive team and Director of Enabling Technologies at the DOE Great Lakes Bioenergy Research Center. Prior to that, Dr. Richmond worked as a bench scientist, project lead and industry consultant, garnering two patents and multiple publications. Along with a doctorate in Cell and Molecular Biology and an M.B.A. from the University of Wisconsin, Madison, she also attended Stanford University as an American Cancer Society fellow and was funded by DARPA for breakthrough research efforts.

Nicole Huber, Ph.D.

Senior Program Manager | nicoleh@alleninstitute.org

Nicole Huber oversees the grant making and grant management activities of the portfolio of bioscience grants in The Paul G. Allen Frontiers Group. Since joining the team in 2013, she has helped expand the portfolio to ~$200M in award funding. In addition, Nicole has led additional philanthropic initiatives including the design and installation of a unique patient care technology for ten major West Coast medical imaging clinics, easing the stress of cancer therapy for over 10,000 patients annually. Prior to joining the Frontiers Group, Nicole was a postdoctoral research associate at the University of Washington, where she also earned her Ph.D. in Biology, advancing the frontiers of in vivo muscle mechanics and publishing in such journals as Science. She received her B.S. in Biology from the University of California, Berkeley.

Casey Elkins

Administrative Project Coordinator | casey.elkins@alleninstitute.org

Casey Elkins provides administrative, event, and operational support for the Paul G. Allen Frontiers Group. Casey brings a strong operations background from the corporate, community, and non-profit sectors, both domestically and internationally. Prior to joining the Allen Institute, he worked for Vulcan Inc., where he oversaw shipping logistics for Vulcan’s various interests worldwide. He holds his M.Phil. in Conflict Resolution and Reconciliation from Trinity College Dublin at Belfast and a B.A. in Religion from Colorado College.

Alexandra Basford

Program Officer, Life Science Research Scout | alexandra.basford@alleninstitute.org

Alexandra Basford creates, implements and assesses the impact of scientific research programs as part of The Paul G. Allen Frontiers Group. She engages in continuous information gathering with thought leaders, organizational leaders and early career investigators worldwide to help identify directions that offer first in opportunities in areas of bioscience that could generate transformative or paradigm-shifting outcomes. Prior to joining the Frontiers Group in 2019, Alexandra spent a decade in scientific publishing in the U.S. and Asia, working as a journal editor, a publisher and a biomedical indexer. She possesses a bachelor’s degree in Biophysics from Scripps College and doctorate in Neuroscience from the University of Minnesota; broad familiarity with basic, clinical and translational research; and bench experience in physiology, molecular biology and imaging.